Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-28

Clinical Trial Update: Pre-Prostatectomy Celecoxib or Placebo [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating celecoxib versus placebo before prostatectomy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Adenocarcinoma of the Prostate, Prostate Cancer | Phase 2 | Status: TERMINATED